시스타틴 C 측정 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별, 방법별, 검체 유형별, 용도별, 지역별, 경쟁별(2020-2030년)

Cystatin C Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Method, By Sample Type, By Application Region and Competition, 2020-2030F

US $ 4,500 ￦ 6,681,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 8,165,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,877,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계의 시스타틴 C 측정 시장은 2024년에 3억 8,554만 달러로 평가되었으며, 2030년까지 CAGR 6.18%로 성장하여 5억 5,249만 달러에 달할 것으로 예측됩니다.

시스타틴 C 측정법은 주로 혈청이나 혈장 등 생체액 내 시스타틴 C 농도를 정량적으로 측정하는 체외 진단 검사로, 신장 기능 평가 및 사구체여과량(GFR) 추정에 신뢰할 수 있는 바이오마커로 작용합니다. 이 측정법은 크레아티닌 기반 검사에 비해 우월한 장점이 있어 이용이 확대되고 있습니다. 시스타틴 C 농도는 근육량, 나이, 성별 등의 요인에 영향을 덜 받는 특징이 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	3억 8,554만 달러
시장 규모 : 2030년	5억 5,249만 달러
CAGR : 2025-2030년	6.18%
가장 빠르게 성장하는 부문	효소면역측정법(ELISA)
최대 시장	북미

주요 시장 촉진요인

시스타틴 C 측정 시장은 시스타틴 C가 조기에 정확한 신장 바이오마커로서 우수하다는 사실이 널리 알려지면서 크게 성장하고 있습니다. 이 단백질은 크레아티닌 측정값에 영향을 미치는 근육량, 나이, 성별, 식습관 등의 교란 요인에 거의 영향을 받지 않기 때문에 사구체여과율을 보다 신뢰성 있고 정확하게 평가할 수 있습니다.

주요 시장 과제

시스타틴 C 시약 및 관련 검사의 높은 비용은 세계 시스타틴 C 측정 시장의 광범위한 성장에 큰 도전이 되고 있습니다. 이 상대적으로 높은 비용은 특히 기존의 저렴한 크레아티닌 분석과 비교할 때 다양한 의료 시스템의 조달 결정에 직접적인 영향을 미칠 수 있습니다.

주요 시장 동향

임상 실험실의 효율성 향상, 인적 오류 감소, 처리 능력 증대의 필요성으로 인해 자동화 분석 시스템에 대한 수요 확대가 두드러진 시장 트렌드로 자리 잡고 있습니다. 자동화는 검체 처리부터 결과 분석까지 복잡한 워크플로우를 효율화하여 대량 검사 대응 및 인력 부족 해소에 필수적입니다.

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 시스타틴 C 측정 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 제품별(분석기, 키트, 시약)
  • 방법별(효소면역측정법(ELISA), 입자 증강 탁도 면역측정법(PETIA), 입자 증강 비탁 면역측정법(PENIA), 화학발광 면역측정법(CLIA), 면역형광법(IFA), 기타)
  • 검체 유형별(혈액, 소변)
  • 용도별(진단, 조사)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 시스타틴 C 측정 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 시스타틴 C 측정 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 시스타틴 C 측정 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 시스타틴 C 측정 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 시스타틴 C 측정 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 세계의 시스타틴 C 측정 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제15장 경쟁 구도

• F. Hoffmann-La Roche Ltd
• Abbott Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Siemens Healthineers AG
• Bio-Techne
• Agilent Technologies, Inc
• Gentian Diagnostics ASA
• Abcam Limited
• Getein Biotech, Inc
• Sino Biological, Inc

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

KSM

영문 목차

영문목차

The Global Cystatin C Assay Market, valued at USD 385.54 Million in 2024, is projected to experience a CAGR of 6.18% to reach USD 552.49 Million by 2030. A Cystatin C assay is an in vitro diagnostic test that quantitatively measures Cystatin C levels in biological fluids, primarily serum or plasma, serving as a reliable biomarker for assessing renal function and estimating glomerular filtration rate (GFR). This assay is increasingly utilized due to its advantages over creatinine-based tests, as Cystatin C levels are less influenced by factors such as muscle mass, age, or sex.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 385.54 Million
Market Size 2030	USD 552.49 Million
CAGR 2025-2030	6.18%
Fastest Growing Segment	Enzyme-Linked Immunosorbent Assay (ELISA)
Largest Market	North America

Key Market Drivers

The market for Cystatin C assays is significantly propelled by the recognized superiority of Cystatin C as an early and accurate renal biomarker. This protein offers a more reliable and precise assessment of glomerular filtration rate because its levels are largely independent of confounding factors such as muscle mass, age, sex, and diet, which often influence creatinine measurements. This intrinsic biological advantage positions Cystatin C as a preferred biomarker for detecting subtle changes in kidney function and facilitating earlier diagnosis. For instance, according to a study published in the Journal of Clinical and Diagnostic Research on March 1, 2024, regression analysis indicated a tighter distribution of results for cystatin C, with an R2 value of 0.67, compared to 0.64 for creatinine, demonstrating its superior predictive ability for GFR.

Key Market Challenges

The elevated cost of Cystatin C reagents and associated testing presents a significant challenge to the widespread growth of the Global Cystatin C Assay Market. This comparative expense, particularly when benchmarked against established and more affordable creatinine assays, directly influences procurement decisions within diverse healthcare systems. The financial disparity strains operational budgets for clinical laboratories, making the adoption of these advanced diagnostics a subject of intense scrutiny regarding cost-effectiveness. Consequently, despite the recognized clinical benefits of Cystatin C assays for more precise renal function assessment, their higher cost hinders broader integration into routine diagnostic panels.

Key Market Trends

The growing demand for automated assay systems represents a significant market trend, driven by the need for enhanced efficiency, reduced manual errors, and increased throughput in clinical laboratories. Automation streamlines complex workflows, from sample handling to result analysis, which is critical for managing high testing volumes and addressing staffing shortages. For instance, the College of American Pathologists, in its 2024 Surveys and Anatomic Pathology Education Programs document, highlighted that it offers more than 700 proficiency testing programs, reflecting the extensive scope of quality assurance in laboratory diagnostics that benefits from automated processes.

Key Market Players

• F. Hoffmann-La Roche Ltd
• Abbott Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Siemens Healthineers AG
• Bio-Techne
• Agilent Technologies, Inc
• Gentian Diagnostics ASA
• Abcam Limited
• Getein Biotech, Inc
• Sino Biological, Inc

Report Scope:

In this report, the Global Cystatin C Assay Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cystatin C Assay Market, By Product:

• Analyzers
• Kits
• Reagents

Cystatin C Assay Market, By Method:

• Enzyme-Linked Immunosorbent Assay (ELISA)
• Particle-Enhanced Turbidimetric Immunoassay (PETIA)
• Particle-enhanced Nephelometric Immunoassay (PENIA)
• Chemiluminescent immunoassay (CLIA)
• Immunofluorescence assay (IFA)
• Others

Cystatin C Assay Market, By Sample Type:

• Blood
• Urine

Cystatin C Assay Market, By Application:

• Diagnostics
• Research

Cystatin C Assay Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Cystatin C Assay Market.

Available Customizations:

Global Cystatin C Assay Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cystatin C Assay Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Analyzers, Kits, Reagents)
  • 5.2.2. By Method (Enzyme-Linked Immunosorbent Assay (ELISA), Particle-Enhanced Turbidimetric Immunoassay (PETIA), Particle-enhanced Nephelometric Immunoassay (PENIA), Chemiluminescent immunoassay (CLIA), Immunofluorescence assay (IFA), Others)
  • 5.2.3. By Sample Type (Blood, Urine)
  • 5.2.4. By Application (Diagnostics, Research)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Cystatin C Assay Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Method
  • 6.2.3. By Sample Type
  • 6.2.4. By Application
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Cystatin C Assay Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Method
      • 6.3.1.2.3. By Sample Type
      • 6.3.1.2.4. By Application
  • 6.3.2. Canada Cystatin C Assay Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Method
      • 6.3.2.2.3. By Sample Type
      • 6.3.2.2.4. By Application
  • 6.3.3. Mexico Cystatin C Assay Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Method
      • 6.3.3.2.3. By Sample Type
      • 6.3.3.2.4. By Application

7. Europe Cystatin C Assay Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Method
  • 7.2.3. By Sample Type
  • 7.2.4. By Application
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Cystatin C Assay Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Method
      • 7.3.1.2.3. By Sample Type
      • 7.3.1.2.4. By Application
  • 7.3.2. France Cystatin C Assay Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Method
      • 7.3.2.2.3. By Sample Type
      • 7.3.2.2.4. By Application
  • 7.3.3. United Kingdom Cystatin C Assay Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Method
      • 7.3.3.2.3. By Sample Type
      • 7.3.3.2.4. By Application
  • 7.3.4. Italy Cystatin C Assay Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Method
      • 7.3.4.2.3. By Sample Type
      • 7.3.4.2.4. By Application
  • 7.3.5. Spain Cystatin C Assay Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Method
      • 7.3.5.2.3. By Sample Type
      • 7.3.5.2.4. By Application

8. Asia Pacific Cystatin C Assay Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Method
  • 8.2.3. By Sample Type
  • 8.2.4. By Application
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Cystatin C Assay Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Method
      • 8.3.1.2.3. By Sample Type
      • 8.3.1.2.4. By Application
  • 8.3.2. India Cystatin C Assay Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Method
      • 8.3.2.2.3. By Sample Type
      • 8.3.2.2.4. By Application
  • 8.3.3. Japan Cystatin C Assay Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Method
      • 8.3.3.2.3. By Sample Type
      • 8.3.3.2.4. By Application
  • 8.3.4. South Korea Cystatin C Assay Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Method
      • 8.3.4.2.3. By Sample Type
      • 8.3.4.2.4. By Application
  • 8.3.5. Australia Cystatin C Assay Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Method
      • 8.3.5.2.3. By Sample Type
      • 8.3.5.2.4. By Application

9. Middle East & Africa Cystatin C Assay Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Method
  • 9.2.3. By Sample Type
  • 9.2.4. By Application
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Cystatin C Assay Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Method
      • 9.3.1.2.3. By Sample Type
      • 9.3.1.2.4. By Application
  • 9.3.2. UAE Cystatin C Assay Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Method
      • 9.3.2.2.3. By Sample Type
      • 9.3.2.2.4. By Application
  • 9.3.3. South Africa Cystatin C Assay Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Method
      • 9.3.3.2.3. By Sample Type
      • 9.3.3.2.4. By Application

10. South America Cystatin C Assay Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Method
  • 10.2.3. By Sample Type
  • 10.2.4. By Application
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Cystatin C Assay Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Method
      • 10.3.1.2.3. By Sample Type
      • 10.3.1.2.4. By Application
  • 10.3.2. Colombia Cystatin C Assay Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Method
      • 10.3.2.2.3. By Sample Type
      • 10.3.2.2.4. By Application
  • 10.3.3. Argentina Cystatin C Assay Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Method
      • 10.3.3.2.3. By Sample Type
      • 10.3.3.2.4. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Cystatin C Assay Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. F. Hoffmann-La Roche Ltd
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Abbott Laboratories Inc.
• 15.3. Thermo Fisher Scientific Inc.
• 15.4. Siemens Healthineers AG
• 15.5. Bio-Techne
• 15.6. Agilent Technologies, Inc
• 15.7. Gentian Diagnostics ASA
• 15.8. Abcam Limited
• 15.9. Getein Biotech, Inc
• 15.10. Sino Biological, Inc

16. Strategic Recommendations

17. About Us & Disclaimer

관련자료